AAOpt 2023: Contact Lens Institute report takeaways
Ariel Cerenzie, OD, FAAO, FSLS, shares highlights from the recently released Contact Lens Institute report on contact lens culture.
AAOpt 2023: Navigating the evolution of glaucoma and MIGS
Gleb Sukhovolskiy discusses his 2023 AAOpt presentation, "Optometrist’s Guide to MIGS and the Continuing Evolution of Glaucoma Treatment."
AAOpt 2023: Understanding nystagmus and providing better patient care
Nystagmus can be an intimidating condition, but understanding the treatment options can help patients feel as if they have more control.
AAOpt 2023: What's new in dry eye?
Lisa Hornick, OD, MBA, FAAO, chats about her AAOpt presentations, "Dry Eye Jeopardy" and "Sunny with a Chance of Tears of Tears: What's in the Forecast for Ocular Surface Dryness Therapies."
AAOpt 2023: The perfect presbyopic patient
Post-hoc data helps shine light on better understanding what patient demographics are best suited for presbyopia drops.
AAOpt 2023: Preventing dropout in glaucoma due to dry eye
At AAOpt, Justin Schweitzer, OD, FAAO, and Selina McGee, OD, FAAO, Dipl ABO, discuss the intersection of dry eye and glaucoma.
AAOpt 2023: Integrating orthokeratology for myopia management
VEW 2023: Phase 3 BRIO-I data for brimochol PF for presbyopia
Ben Bergo, CEO of Visus, shares data from the company's pivotal phase 3 BRIO-1 trial, as well as answers questions about Brimochol PF.
VEW 2023: How — and how not — to use AI in eye care
Easy Anyama shares key takeaway points from "Vision care in the age of ChatGPT" and "Advances in AI and diagnosis for BIPOC populations" at Vision Expo West 2023 in Las Vegas.
VEW: Creating a contact lens culture in your practice
The Contact Lens Institute and The Vision Council presented a sneak peek of its forthcoming report, “The Culture Calculation: Data-Backed Behaviors for Contact Lens Success,” which will be published in mid-October 2023.
VEW 2023: Predicting the future of keratoconus care
Justin Schweitzer, OD, FAAO, discusses his talk, "Current trends in keratoconus management," at Vision Expo West 2023 in Las Vegas, Nevada.
VEW 2023: The greatest contact lens course ever offers a comprehensive overview of all things contact lens
The course reviews fitting various contact lenses, looks at practice management essentials, and discusses treatment of contact lens complications.
VEW 2023: How to put contact lenses to work for you
Lyndon Jones, PhD, DSc, FCOptom, FAAO, showcases topics discussed in the Global Contact Lens Forum at Vision Expo West 2023.
Optometry Giving Sight shares VEW plans, previews AAOpt activities
OGS has begun its funding season as the organization looks ahead to wrapping up 2023 and kicking off 2024.
FDA approves Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of pharmacologically-induced mydriasis
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
How to implement a custom contact lens fitting model into your practice
Luis Rojas, OD, shares his tips and tricks for getting the best fit for multifocal contact lenses, as well as how to leverage custom fittings as a service as a marketing tool.
Exciting things in the pipeline for the American Academy of Orthokeratology and Myopia Control
AAOMC is focusing on new membership growth, diversity, and how they can continue to move the needle in myopia management.
Tarsus announces Xdemvy availability at pharmacies nationwide
Lotilaner ophthalmic solution 0.25% (Xdemvy) was approved by the FDA in July, making it the first and only approved treatment for Demodex blepharitis.
Historic signing at AOA: All about the 13% Promise
The AOA joins several industry leaders in taking the pledge to increase opportunities for Black optometrists and students
EyeCon 2023: Overview with Dr Kelly Nichols
CRU 2023: Learn to care for your patients' retinas with genetic testing
The 2023 CRU Eye Symposium in Napa Valley brings exciting presentation topics, including the retina and genetic testing.
FDA approves XDEMVY, the first and only treatment for Demodex blepharitis
Dr Selina McGee, OD, FAAO, Dipl ABO, met with Optometry Times to discuss the recent FDA approval of XDEMVY, a treatment for Demodex blepharitis, from Tarsus Pharmaceuticals.
EyeCon 2023: Bringing collaborative OD and MD education to life
Hear from A. Paul Chous, OD, MA, FAAO, and what to look forward to during the 2023 EyeCon meeting December 1-2 in Sanibel Harbour, FL.
CRU 2023: New technologies and advances in the contact lens field, plus the new paradigm in specialty lenses
CRU 2023 will cover a host of topics, including a co-led presentation by Drs Deborah Jacobs and Melissa Barnett on the latest advancements in the contact lens field.
Opthea announces nonproprietary drug name “sozinibercept” for OPT-302
Opthea’s lead biologic drug candidate OPT-302, which is under investigation for the treatment of wet AMD, received nonproprietary drug name sozinibercept, which is a critical step in the FDA approval process.
Meet the LEO founding board: Dr Diana Canto-Sims
Diana Canto-Sims, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).
Meet the LEO founding board: Dr Lina T Arengo
Lina T Arango, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).
CRU 2023: Experience Napa Valley as part of an intimate eye care symposium
Learn about the second annual CRU Eye Symposium, the intentions behind the meeting, and what to expect.
NOA 2023: Dissecting the state of optometry
Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.
NOA 2023: Insights and lessons from a pediatric patient case
At NOA 2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds.
2 Clarke Drive Cranbury, NJ 08512